Vendor source

Reviewed 6 Jul 2026

Completeness Comprehensive (83%)

EchoGo Pro

Ultromics

Outcomes-based AI system that predicts coronary artery disease.

Supported by 1 paper

Key Features

  • Automated segmentation
  • Risk prediction

General Information

Product name

EchoGo Pro

Company

Modality

Ultrasound

Main task

Not specified

Subspeciality

Cardiac

Disease targeted

Coronary Artery Disease

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class I

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

Stress Echo

Input format

DICOM

Output

PDF Report with key quantification and findings

Output format

PDF

Integration

Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased

Deployment

Cloud-based, Locally virtualized (virtual machine, Docker)

Trigger for analysis

Automatically, right after the image acquisition

Processing time

10 - 60 seconds

Population

All stress echo indications in adults

Market Presence

On market since

03-2020

AI Platforms

Resellers

Caption Health

Countries present

2

Paying clinical customers

1

Research/test users

2

Pricing Information

Pricing model

Subscription

Based on

Number of analyses

Source: Vendor | First published: Nov 24, 2021 | Last updated: Jul 6, 2026